WES Pharma Inc
FDA Approved Drugs

WES Pharma Inc

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 11
  • Latest Approval Date Jun 06, 2022
  • Data Source FDA
  • First Approval Date Oct 30, 2017
Company Overview

Company

WES Pharma Inc

Country

U.S.A

Social Profiles

Company Snapshot

WES Pharma Inc

1221 Tech Court, Westminster, MD

U.S.A

www.wespharma.com/ info@wespharma.com View on Map
FDA Approved Drug Records ( 11 records )
2020
17 Jul
RX Application: 209069

Drug Name

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE;EQ 0.5MG BASE

Approval Date

2020-07-17

209069 / 1

Active Ingredient

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Application Number

209069

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE;EQ 0.5MG BASE

Approval Date

2020-07-17

Regulatory Status

RX

2020
17 Jul
RX Application: 209069

Drug Name

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 8MG BASE;EQ 2MG BASE

Approval Date

2020-07-17

209069 / 2

Active Ingredient

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Application Number

209069

Product Number

2

Dosage Form

-

Strength

EQ 8MG BASE;EQ 2MG BASE

Approval Date

2020-07-17

Regulatory Status

RX

2017
30 Oct
RX Application: 210211

Drug Name

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Product Number

1

Dosage Form

-

Strength

325MG;5MG

Approval Date

2017-10-30

210211 / 1

Active Ingredient

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Application Number

210211

Product Number

1

Dosage Form

-

Strength

325MG;5MG

Approval Date

2017-10-30

Regulatory Status

RX

2017
30 Oct
RX Application: 210211

Drug Name

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Product Number

2

Dosage Form

-

Strength

325MG;7.5MG

Approval Date

2017-10-30

210211 / 2

Active Ingredient

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Application Number

210211

Product Number

2

Dosage Form

-

Strength

325MG;7.5MG

Approval Date

2017-10-30

Regulatory Status

RX

2017
30 Oct
RX Application: 210211

Drug Name

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Product Number

3

Dosage Form

-

Strength

325MG;10MG

Approval Date

2017-10-30

210211 / 3

Active Ingredient

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Application Number

210211

Product Number

3

Dosage Form

-

Strength

325MG;10MG

Approval Date

2017-10-30

Regulatory Status

RX

2019
08 Mar
RX Application: 211023

Drug Name

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Product Number

1

Dosage Form

-

Strength

325MG/15ML;7.5MG/15ML

Approval Date

2019-03-08

211023 / 1

Active Ingredient

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Application Number

211023

Product Number

1

Dosage Form

-

Strength

325MG/15ML;7.5MG/15ML

Approval Date

2019-03-08

Regulatory Status

RX

2018
21 Mar
RX Application: 207510

Drug Name

OXYCODONE AND ACETAMINOPHEN

Product Number

1

Dosage Form

-

Strength

325MG;5MG

Approval Date

2018-03-21

207510 / 1

Active Ingredient

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

Application Number

207510

Product Number

1

Dosage Form

-

Strength

325MG;5MG

Approval Date

2018-03-21

Regulatory Status

RX

2018
21 Mar
RX Application: 207510

Drug Name

OXYCODONE AND ACETAMINOPHEN

Product Number

2

Dosage Form

-

Strength

325MG;7.5MG

Approval Date

2018-03-21

207510 / 2

Active Ingredient

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

Application Number

207510

Product Number

2

Dosage Form

-

Strength

325MG;7.5MG

Approval Date

2018-03-21

Regulatory Status

RX

2018
21 Mar
RX Application: 207510

Drug Name

OXYCODONE AND ACETAMINOPHEN

Product Number

3

Dosage Form

-

Strength

325MG;10MG

Approval Date

2018-03-21

207510 / 3

Active Ingredient

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

Application Number

207510

Product Number

3

Dosage Form

-

Strength

325MG;10MG

Approval Date

2018-03-21

Regulatory Status

RX

2022
06 Jun
RX Application: 213062

Drug Name

POTASSIUM CHLORIDE

Product Number

1

Dosage Form

-

Strength

20MEQ/15ML

Approval Date

2022-06-06

213062 / 1

Active Ingredient

POTASSIUM CHLORIDE

Application Number

213062

Product Number

1

Dosage Form

-

Strength

20MEQ/15ML

Approval Date

2022-06-06

Regulatory Status

RX

2022
06 Jun
RX Application: 213062

Drug Name

POTASSIUM CHLORIDE

Product Number

2

Dosage Form

-

Strength

40MEQ/15ML

Approval Date

2022-06-06

213062 / 2

Active Ingredient

POTASSIUM CHLORIDE

Application Number

213062

Product Number

2

Dosage Form

-

Strength

40MEQ/15ML

Approval Date

2022-06-06

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    11 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
11 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Application Number

209069

Product Number

1

Active Ingredient

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Dosage Form

-

Strength

EQ 2MG BASE;EQ 0.5MG BASE

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.